Russell Szmulewitz, MD

APPOINTMENTS

  • Assistant Professor of Medicine, Section of Hematology/Oncology

EDUCATION

  • MD, 2003, The University of Chicago, Pritzker School of Medicine
  • BA, 1998, Northwestern University

CONTACT INFORMATION

The University of Chicago 
AMB I-212
Chicago, IL  60637

rszmulew@medicine.bsd.uchicago.edu

Phone: 773-702-7609

RESEARCH SUMMARY 

Russell Szmulewitz, MD, is an expert in the treatment and management of prostate, bladder, kidney, and testicular cancers. His clinical focus is on the treatment of patients with advanced prostate cancer, with particular expertise in the use of leading-edge hormonal, targeted, and immunotherapies. Dr. Szmulewitz works in close collaboration with urologists, radiation oncologists, and geriatricians who also specialize in the care of prostate cancer patients.

His research bridges the clinic and laboratory and focuses on the process of prostate cancer metastasis. In particular, his research attempts to better define the steps involved in metastatic progression and evolution to castration resistance in prostate cancer, with the goal of developing targeted therapies for these processes. In addition, Dr. Szmulewitz’s laboratory is developing strategies to isolate and interrogate circulating tumor cells (CTC) to better understand the biology of prostate cancer, and eventually personalize care based on this individualized biology.

Dr. Szmulewitz is particularly involved in therapeutic development for prostate cancer. He is an investigator on many clinical research trials focusing on immunotherapy, anti-angiogentic, and other novel targeted therapies for prostate cancer.

RESEARCH PAPERS ON PUBMED

Research Papers on PubMed